← brief for 2026-10-15 · Slowing decline

Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects.

Key takeaways

This is a review of a class of drugs called SGLT2 inhibitors. It looks at how they work and their side effects. There is no abstract, so we have not read the study. There are no results yet.

Who did this work

Woodowrth S · Hayden R

Source

Paper · PubMed, the drug frontier · 2026 Oct 1
https://pubmed.ncbi.nlm.nih.gov/42877252/